What autoimmune diseases cause telangiectasias on the face, lips, and tongue?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Systemic Sclerosis (Scleroderma) is the Primary Autoimmune Disease Causing Facial, Lip, and Tongue Telangiectasias

Systemic sclerosis (scleroderma) is the autoimmune disease most characteristically associated with telangiectasias on the face, lips, and tongue, occurring in 75-100% of patients across all disease subtypes 1. These telangiectasias are a hallmark feature, particularly prominent in limited cutaneous systemic sclerosis (CREST syndrome), and serve as clinical markers of disease severity and duration 2, 3.

Clinical Pattern in Systemic Sclerosis

The telangiectasias in systemic sclerosis follow specific patterns:

  • "Ramosus" type: Most frequently involves the face, neck, and chest
  • "Telangiectatic mats" type: Typically appears on upper extremities and is the only type that characteristically appears on the lips 1
  • The number of telangiectasias correlates significantly with disease duration (p = 0.009) 4
  • Distribution appears random on the face and hands 4

Facial telangiectasias in systemic sclerosis are frequent, especially with CREST syndrome (calcinosis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia) 3. Multiple studies indicate these telangiectasias serve as markers of disease severity, pulmonary arterial hypertension, and esophageal involvement 3.

Other Autoimmune Diseases with Telangiectasias

While systemic sclerosis is the primary culprit, other autoimmune conditions can present with facial telangiectasias, though less commonly:

Systemic Lupus Erythematosus (SLE)

  • Telangiectasias can occur but are not a defining feature 1
  • Neonatal lupus erythematosus presents a unique scenario where facial telangiectasias (especially peri-orbital and scalp) persist even after typical annular lesions fade 5
  • The telangiectasias in neonatal lupus are a rare but permanent complication that remains after antibodies clear 5

Dermatomyositis

  • Can present with facial erythematous changes, though the hallmark is the heliotrope rash (purple-violet upper eyelids) rather than discrete telangiectasias 3

Mixed Connective Tissue Disease (MCTD)

  • May present with telangiectasias as part of overlapping features with systemic sclerosis 6

Critical Diagnostic Pitfall

Do not confuse hereditary hemorrhagic telangiectasia (HHT) with autoimmune disease. HHT is a genetic disorder (mutations in endoglin and ALK-1 genes) that presents with telangiectasias on face, lips, and oral mucosa, but it is NOT autoimmune 4, 6. The microscopic appearance and distribution of telangiectasias in systemic sclerosis are remarkably similar to HHT, which may involve similar TGF-β receptor family protein disorders 4. When a patient presents with prominent telangiectasias, epistaxis, and some features of connective tissue disease, genetic testing for HHT should be considered even if autoimmune markers are present 6.

Key Distinguishing Features to Look For

When evaluating telangiectasias on face, lips, and tongue:

  • Systemic sclerosis: Look for sclerodactyly, Raynaud phenomenon, digital ulcers, skin thickening, and calcinosis. Mat-like telangiectasias on lips are highly characteristic 7
  • Neonatal lupus: Occurs in infants with maternal anti-Ro antibodies; telangiectasias appear after annular lesions fade 5
  • HHT (non-autoimmune): Family history, recurrent epistaxis, visceral arteriovenous malformations, absence of other connective tissue disease features

The presence of mat-like telangiectasias specifically on the lips strongly suggests systemic sclerosis rather than other autoimmune conditions 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.